The investigators plan to administer acetaminophen (Tylenol) for the treatment of fever in laboring patients by either an oral or intravenous (IV) route. The investigators want to see if the maternal fever will decrease faster with the IV or the oral dose. The investigators also want to look at other outcomes such as the cesarean section rate, the rate of neonatal intensive care unit admissions in both groups.
| Study Type: |
Interventional (Clinical Trial) |
| Estimated Enrollment: |
168 participants |
| Allocation: |
Randomized |
| Intervention Model: |
Parallel Assignment |
| Masking: |
Triple (Participant, Care Provider, Investigator) |
| Primary Purpose: |
Treatment |
| Official Title: |
Randomized Control Trial of Intravenous Acetaminophen (OFIRMEV) for the Reduction of Intrapartum Maternal Feverrrr and Fetal Tachycardia |
| Actual Study Start Date: |
December 2016 |
| Estimated Primary Completion Date: |
July 2018 |
| Estimated Study Completion Date: |
July 2018 |
Contact
| Contact: Nisha Lakhi, MD |
7188182109 |
nlakhi@yahoo.com |
| Contact: Michael Moretti, MD |
7188182109 |
Mmoretti@rumcsi.org |
| ClinicalTrials.gov Identifier: |
NCT02625454 |
For enrollment please visit
www.clinicaltrials.gov.
